Abstract
Pulmonary vein isolation (PVI) is a highly specialized, minimally-invasive and increasingly accessible treatment for symptomatic Atrial Fibrillation (AF), providing significant benefits in decreasing arrhythmic burden and improving patients' functional quality of life and wellbeing. According to the recently released Canadian Cardiovascular Society Atrial Fibrillation Guidelines (2010), there is moderate level of evidence to support recommendations for the use of catheter ablation in drug refractory AF.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
